博雅生物：目前公司各项生产经营正常有序

Core Viewpoint - The company, Boya Bio (300294), is closely monitoring market conditions and policy changes while maintaining normal and orderly production and operations [1] Group 1 - The company is actively responding to investor inquiries regarding its operational status [1] - The company emphasizes its focus on the current market environment and policy shifts [1]